Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ivan Pasic

Showing results (81-90 of 91) with videos related to

Pageof 10
Sort By:
Bone Marrow Transplantation|July 2, 2020
Pilot prospective study of Frailty and Functionality in routine clinical assessment in allogeneic hematopoietic cell transplantationMaria Queralt Salas, Eshetu G Atenafu, Ora Bascom, et al.
Transplantation and Cellular Therapy|January 28, 2024
Outcomes of Antithymocyte Globulin-Post-Transplantation Cyclophosphamide-Cyclosporine-Based versus Antithymocyte Globulin-Based Prophylaxis for 10/10 HLA-Matched Unrelated Donor Allogeneic Hematopoietic Cell TransplantationMaria Queralt Salas, Tommy Alfaro-Moya, Eshetu G Atenafu, et al.
Transplantation and Cellular Therapy|July 12, 2023
Interaction Between High-Dose Intravenous Busulfan and Post-Transplantation Cyclophosphamide on Hemorrhagic Cystitis After Allogeneic Hematopoietic Cell TransplantationAbel Santos Carreira, Maria Queralt Salas, Mats Remberger, et al.
Bone Marrow Transplantation|December 16, 2022
Impact of hematopoietic cell transplant frailty scale on transplant outcome in adultsMaria Queralt Salas, Eshetu G Atenafu, Ivan Pasic, et al.
Bone Marrow Transplantation|August 24, 2023
HCT frailty scale for younger and older adults undergoing allogeneic hematopoietic cell transplantationMaria Queralt Salas, Eshetu G Atenafu, Ivan Pasic, et al.
British Journal of Haematology|September 14, 2025
Endothelial activation and stress index (EASIX) as a biomarker to predict ruxolitinib failure for steroid-refractory acute graft-versus-host disease treatmentSergio Rodriguez-Rodriguez, Nihar Desai, Carol Chen, et al.
Haematologica|February 2, 2023
Clonal hematopoiesis in the donor does not adversely affect long-term outcomes following allogeneic hematopoietic stem cell transplantation: result from a 13-year follow-upKyoung Ha Kim, TaeHyung Kim, Igor Novitzky-Basso, et al.
Ejhaem|September 2, 2022
The 17-gene stemness score associates with relapse risk and long-term outcomes following allogeneic haematopoietic cell transplantation in acute myeloid leukaemiaDennis D H Kim, Igor Novitzky Basso, Taehyung Simon Kim, et al.
Bone Marrow Transplantation|March 26, 2021
Prognostic impact of the adverse molecular-genetic profile on long-term outcomes following allogeneic hematopoietic stem cell transplantation in acute myeloid leukemiaGeorgina Daher-Reyes, TaeHyung Kim, Igor Novitzky-Basso, et al.
Blood Advances|August 15, 2025
The MAGIC Composite Response: A Novel Endpoint Integrating Clinical and Biomarker Parameters for Acute GVHDYu Akahoshi, Joseph Portelli, Nikolaos Katsivelos, et al.
Pageof 10

Showing results (81-90 of 91) with videos related to

Sort By:
Pageof 10
Bone Marrow Transplantation|July 2, 2020
Pilot prospective study of Frailty and Functionality in routine clinical assessment in allogeneic hematopoietic cell transplantationMaria Queralt Salas, Eshetu G Atenafu, Ora Bascom, et al.
Transplantation and Cellular Therapy|January 28, 2024
Outcomes of Antithymocyte Globulin-Post-Transplantation Cyclophosphamide-Cyclosporine-Based versus Antithymocyte Globulin-Based Prophylaxis for 10/10 HLA-Matched Unrelated Donor Allogeneic Hematopoietic Cell TransplantationMaria Queralt Salas, Tommy Alfaro-Moya, Eshetu G Atenafu, et al.
Transplantation and Cellular Therapy|July 12, 2023
Interaction Between High-Dose Intravenous Busulfan and Post-Transplantation Cyclophosphamide on Hemorrhagic Cystitis After Allogeneic Hematopoietic Cell TransplantationAbel Santos Carreira, Maria Queralt Salas, Mats Remberger, et al.
Bone Marrow Transplantation|December 16, 2022
Impact of hematopoietic cell transplant frailty scale on transplant outcome in adultsMaria Queralt Salas, Eshetu G Atenafu, Ivan Pasic, et al.
Bone Marrow Transplantation|August 24, 2023
HCT frailty scale for younger and older adults undergoing allogeneic hematopoietic cell transplantationMaria Queralt Salas, Eshetu G Atenafu, Ivan Pasic, et al.
British Journal of Haematology|September 14, 2025
Endothelial activation and stress index (EASIX) as a biomarker to predict ruxolitinib failure for steroid-refractory acute graft-versus-host disease treatmentSergio Rodriguez-Rodriguez, Nihar Desai, Carol Chen, et al.
Haematologica|February 2, 2023
Clonal hematopoiesis in the donor does not adversely affect long-term outcomes following allogeneic hematopoietic stem cell transplantation: result from a 13-year follow-upKyoung Ha Kim, TaeHyung Kim, Igor Novitzky-Basso, et al.
Ejhaem|September 2, 2022
The 17-gene stemness score associates with relapse risk and long-term outcomes following allogeneic haematopoietic cell transplantation in acute myeloid leukaemiaDennis D H Kim, Igor Novitzky Basso, Taehyung Simon Kim, et al.
Bone Marrow Transplantation|March 26, 2021
Prognostic impact of the adverse molecular-genetic profile on long-term outcomes following allogeneic hematopoietic stem cell transplantation in acute myeloid leukemiaGeorgina Daher-Reyes, TaeHyung Kim, Igor Novitzky-Basso, et al.
Blood Advances|August 15, 2025
The MAGIC Composite Response: A Novel Endpoint Integrating Clinical and Biomarker Parameters for Acute GVHDYu Akahoshi, Joseph Portelli, Nikolaos Katsivelos, et al.
Pageof 10